For those who are long-term investors, do you think GC will still be able to uplist this year? Given the delay in enrollment for the bridge study, I'm starting to question the feasibility of uplisting this year.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links